These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 12122491
1. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N. Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491 [Abstract] [Full Text] [Related]
2. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Rénéric JP, Bouvard M, Stinus L. Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533 [Abstract] [Full Text] [Related]
3. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems. Tachibana K, Matsumoto M, Koseki H, Togashi H, Kojima T, Morimoto Y, Yoshioka M. J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668 [Abstract] [Full Text] [Related]
4. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP. Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386 [Abstract] [Full Text] [Related]
5. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters. Bandoh T, Hayashi M, Ino K, Takada S, Ushizawa D, Hoshi K. Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386 [Abstract] [Full Text] [Related]
6. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release. Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T, Kaneko S. Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436 [Abstract] [Full Text] [Related]
7. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats. Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Tanaka T, Masui T, Koyama T. Eur J Pharmacol; 2008 Apr 28; 584(2-3):285-90. PubMed ID: 18336812 [Abstract] [Full Text] [Related]
9. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats. Saitoh A, Yamaguchi K, Tatsumi Y, Murasawa H, Nakatani A, Hirose N, Yamada M, Yamada M, Kamei J. Psychopharmacology (Berl); 2007 May 28; 191(4):857-65. PubMed ID: 17318509 [Abstract] [Full Text] [Related]
18. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. Tordera RM, Monge A, Del Río J, Lasheras B. Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683 [Abstract] [Full Text] [Related]
19. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Bel N, Artigas F. Neuropsychopharmacology; 1999 Dec 03; 21(6):745-54. PubMed ID: 10633480 [Abstract] [Full Text] [Related]
20. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F. Synapse; 1994 Dec 03; 18(4):294-7. PubMed ID: 7886621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]